12-Oct-2008
Story Timeline: 42 days
A novel therapy using a miniature nerve stimulator instead of medication for the treatment of profoundly disabling headache disorders improved the experience of pain by 80-95 percent, according to a new study from the University of California, San Francisco and the National Hospital for Neurology and Neurosurgery in London. The findings give doctors the promise of a non-drug treatment option for pain sufferers unable to tolerate indometacin, the standard medication known to cause stomach bleeding in some patients. Findings are reported online at www.thelancet.com and also will appear in the November 2008 issue of Lancet Neurology. Up to 35 million Americans suffer migraine and other forms of headache, according to the American Academy of Neurology. "We need a range of treatments to offer patients whose lives are taken over by...
[read full story]